• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文会议>Atlanta Conference on Science and Innovation Policy >Raising capital with uncertainty: Overpricing initial public offering for science-based firms with multiple ties to the food and drug administration
【24h】

Raising capital with uncertainty: Overpricing initial public offering for science-based firms with multiple ties to the food and drug administration

机译：提高资本与不确定性：对食品和药物管理局的多个联系的基于科学公司的首次公开发布

获取原文
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

I study the effect of indirect ties between the firm's scientific advisory board members and the Food and Drug Administration advisory committees on underwriter prestige, underwriting fee, underpricing and the initial offering price range for firms pursuing highly uncertain opportunities. Prestigious underwriters compete to underwrite securities offered by firms connected to the regulator. This result in overpricing even though the underwriter seeks to enforce underpricing. The findings contribute to the Coase-Knight debate about the role of uncertainty for firm boundaries.
机译：我研究了公司科学咨询委员会成员与食品和药物管理咨询委员会对承销商声望，承保费，估计的初始发行价格范围，以获得高度不确定的机会的效果。着名的承销商争夺公司与监管机构相关的公司提供的证券。即使承销商试图强制实施估计，这也导致过度定价。调查结果有助于争论关于不确定性对公司界限的作用的争论。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号